Clinical trial
Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)
NCT00141193 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00141193 |
|---|---|
| Title | Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP) |
| Official title | Clinical Protocol For a Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Celecoxib (SC-58635) In The Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP) |
| Acronym | PRESAP |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Adenoma |
| Intervention type | Drug |
| Interventions | Celecoxib |
| Enrollment | 1,561 |
| Start date | Feb 1, 2001 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Sep 1, 2005 |
| Last update posted | Aug 6, 2008 |
| Countries | Australia, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, France, Germany, Hong Kong and 20 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: